Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report)'s stock price shot up 7.2% during mid-day trading on Monday . The company traded as high as $5.50 and last traded at $5.52. 67,575 shares traded hands during trading, a decline of 91% from the average session volume of 724,288 shares. The stock had previously closed at $5.15.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on DH shares. Barclays reiterated an "underweight" rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday, January 13th. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Finally, Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an "equal weight" rating and a $5.00 price target on the stock. Two analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $5.72.
View Our Latest Research Report on DH
Definitive Healthcare Trading Up 3.8 %
The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a market cap of $628.45 million, a PE ratio of -1.75, a P/E/G ratio of 3.94 and a beta of 1.45. The company's 50 day moving average price is $4.50 and its two-hundred day moving average price is $4.40.
Insiders Place Their Bets
In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company's stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 14.84% of the company's stock.
Institutional Trading of Definitive Healthcare
A number of hedge funds and other institutional investors have recently modified their holdings of DH. The Manufacturers Life Insurance Company lifted its position in Definitive Healthcare by 17.0% in the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company's stock valued at $125,000 after acquiring an additional 3,332 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Definitive Healthcare by 9.7% in the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company's stock valued at $181,000 after purchasing an additional 3,874 shares in the last quarter. Rhumbline Advisers raised its holdings in shares of Definitive Healthcare by 5.2% in the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company's stock worth $334,000 after acquiring an additional 4,034 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Definitive Healthcare by 18.1% during the 4th quarter. Canada Pension Plan Investment Board now owns 29,300 shares of the company's stock worth $120,000 after purchasing an additional 4,500 shares during the last quarter. Finally, Glenmede Trust Co. NA grew its stake in Definitive Healthcare by 41.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after acquiring an additional 5,362 shares during the period. 98.67% of the stock is owned by institutional investors and hedge funds.
About Definitive Healthcare
(
Get Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
See Also
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
